Infographic highlighting some of the results from the 2022 California Pharmacist Survey. Pharmacists were asked about their furnishing of naloxone and syringe without an outside provider’s prescription. Includes some policy implications.
Supervised consumption sites (SCS) are harm reduction programs in which people who inject drugs (PWID) bring their previously obtained drugs to consume in a supervised setting. We modeled the potential impact of SCS implementation on HIV and HCV incidence among PWID in three California counties: San Francisco, Los Angeles, and San Diego and found that […]
In the fall of 2021, the California HIV/AIDS Policy Research Centers conducted an online survey to document the direct impact of COVID-19 on healthcare and social services providers working to address HIV, viral hepatitis and sexually transmitted infections (STIs). Survey respondents included 30 organizations that submitted complete surveys. As a response to the COVID-19 physical […]
On November 10, 2021, the California HIV/AIDS Policy Research Centers (CHPRC) and the statewide End the Epidemics coalition (ETE) convened a community meeting to discuss these challenges and to identify policy and research priorities for improving HIV, viral hepatitis, STI, and harm reduction services. The event brought together over a hundred advocates, researchers, public health […]
On June 4, 2021, the Southern California HIV/AIDS Policy Research Center (SCHPRC) hosted a launchmeeting for San Diego County, organized on the heels of a regional listening session led by the NIHOffice of AIDS Research. During this launch event, we were able to focus on policy research needs in San Diego County and to engage […]
The COVID-19 pandemic has led to significant disruptions in California’s efforts to expand and improve services for HIV, hepatitis C, sexually transmitted diseases, and harm reduction. On November 18, 2020, the California HIV/AIDS Policy Research Centers and the End the Epidemics coalition convened a community meeting to discuss these challenges and to identify priorities for […]
In the second of a two-part series, we explore the impact of the opioid epidemic on HIV and other health conditions in California and Nevada. Downstream consequences of the U.S. opioid epidemic, including the many lives left in its wake, are a reminder that efforts to combat infectious disease must begin with the search for […]
